Skip to main navigation Skip to search Skip to main content

An information-theoretic analysis of genetics, gender and age in cancer patients

  • Gurinder Singh Atwal
  • , Raúl Rabadán
  • , Guillermina Lozano
  • , Louise C. Strong
  • , Mariëlle W.G. Ruijs
  • , Marjanka K. Schmidt
  • , Laura J. van't Veer
  • , Heli Nevanlinna
  • , Johanna Tommiska
  • , Kristiina Aittomäki
  • , Gaelle Bougeard
  • , Thierry Frebourg
  • , Arnold J. Levine
  • , Gareth L. Bond

Research output: Contribution to journalArticlepeer-review

Abstract

Germline genetics, gender and hormonal signaling pathways are all well described modifiers of cancer risk and progression. Although and improved understanding of how germline genetic variants interact with other cancer risk factors may allow better prevention and treatment of human cancer, measuring and quantifying these interactions is challenging, in other areas of research, Information Theory has been used to quantitatively describe similar multivariate interactions. We implemented a novel information-theoretic analysis to measure the joint effect of a high frequency germline genetic variant of the p53 tumor suppressor pathway (MDM2 SNP309 T/G) and gender on clinical cancer phenotypes. This analysis quantitatively describes synergistic interactions among gender, the MDM2 SNP309 locus, and the age of onset of tumorigenesis in p53 mutation carriers, These results offer a molecular genetic basis for the observed sexual dimorphism of cancer risk in p53 mutation carriers and a model is proposed that suggests a novel cancer prevention strategy for p53 mutation carriers.

Original languageEnglish (US)
Article numbere1951
JournalPloS one
Volume3
Issue number4
DOIs
StatePublished - Apr 9 2008

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology
  • General Agricultural and Biological Sciences
  • General

MD Anderson CCSG core facilities

  • Biospecimen Extraction Facility

Fingerprint

Dive into the research topics of 'An information-theoretic analysis of genetics, gender and age in cancer patients'. Together they form a unique fingerprint.

Cite this